Role of GSK-3β in Alzheimer's disease pathology

Drug Development Research

Volumn 56, Issue 3, 2002, Pages 491-510

  Planel, Emmanuel ^a   Sun, Xiaoyan ^a   Takashima, Akihiko ^a,b  

^a Brain Science Institute   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Amyloid ; APP; GSK 3 ; Insulin; Kinesin; Neurofibrillary tangles; Phosphatase; Pro apoptosis; Tau

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; KINESIN; PRESENILIN 1; TAU PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; CELL DEATH; CLINICAL PATHWAY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME REGULATION; HUMAN; IN VITRO STUDY; INSULIN METABOLISM; LONGEVITY; MOLECULAR EVOLUTION; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SENILE PLAQUE;

EID: 0036660263     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10100     Document Type: Review

References (233)

1. Alberts AS, Arias J, Hagiwara M, Montminy MR, Feramiseo JR. 1994. Recombinant cyclic AMP response element binding protein (CREB) phosphorylated on Ser-133 is transcriptionally active upon its introduction into fibroblast nuclei. J BioI Chem 269:7623-7630.
2. Alonso AC, Zaidi T, Novak M, Grundke-Iqbal, lqbal K. 2001. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98:6923-6928.
3. Alvarez G, Munoz-Montano JR, Satrustegui J, Avila J, Bogonez E, Diaz-Nido J. 1999. Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett 453:260-264.
4. Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR. 1995. English translation of Alzheimer's 1907 article, Uber eine eigenartige Erkankung der Hirnrinde, Clin Anat 8:429-431.
5. Anderton BH, Brion JP, Couck AM, Davis DR, Gallo JM, Hanger DP, Ladhani K, Latimer DA, Lewis C, Lovestone S, et al. 1995. Modulation of PHF-like tau phosphorylation in cultured neurones and transfected cells. Neurobiol Aging 16:389-397; discussion 398-402.
6. Aplin AE, Gibb GM, Jacobsen JS, Gallo JM, Anderton BH. 1996. In vitro phosphorylation, of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta. J Neurochem 67:699-707.
7. Aplin AE, Jacobsen JS, Anderton BH, Gallo JM. 1997. Effect of increased glycogen synthase kinase-3 activity upon the maturation of the amyloid precursor protein in transfected cells. Neuroreport 8:639-643
8. Arnold SE, Gur RE, Shapiro RM, Fisher KR, Moberg PJ, Gibney MR, Gur RC, Blackwell P, Trojanowski JQ. 1995. Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients. Am J Psychiatry 152:731-737.
9. Ashman JB, Hall ES, Eveleth J, Boekelheide K. 1992. Tau, the neuronal heat-stable microtubule-associated protein, is also present in the cross-linked microtubule network of the testicular spermatid manchette. Biol Reprod 46:120-129.
10. Baum L, Seger R, Woodgett JR, Kawabata S, Maruyama K, Koyama M, Silver J, Saitoh T. 1995. Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement. Brain Res Mol Brain Res 34:1-17.
11. Baum L, Hansen L, Masliah E, Saitoh T. 1996. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation. Mol Chem Neuropathol 29:253-261.
12. Beasley C, Cotter D, Khan N, Pollard C, Sheppard P, Varndell I, Lovestone S, Anderton B, Everall I. 2001. Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia. Neurosci Lett 302:117-120.
13. Bennecib M, Gong C, Grundke-Iqbal I, Iqbal K. 2000. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett 485:87-93.
14. Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E. 1993. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11:153-163.
15. 2 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells. Brain Res Mol Brain Res 71:69-77
16. Bijur GN, De Sarno P, Jope RS. 2000. Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J Biol Chem 275:7583-7590.
17. Billingsley ML, Kincaid RL. 1997. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 323:577-591.
18. Binder LI, Frankfurter A, Rebhun LI. 1985. The distribution of tau in the mammalian central nervous system. J Cell Biol 101:1371-1378.
19. Blendy JA, Kaestner KH, Schmid W, Gass P, Schutz G. 1996. Targeting of the CREB gene leads to up-regulation of a novel CREB mRNA isoform. EMBO J 15:1098-1106.
20. Boyt AA, Taddei TK, Hallmayer J, Helmerhorst E, Gandy SE, Craft S, Martins RN. 2000. The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein. Neuroscience 95:727-734.
21. Braak H, Braak E. 1997. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351-357.
22. Braak E, Braak H, Mandelkow EM. 1994. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta NeuropathoI 87:554-.567.
23. Brady RM, Zinkowski RP, Binder Ll. 1995. Presence of tau in isolated nuclei from human brain. Neurobiol Aging 16:479-486.
24. Braeckman BP, Houthoofd K, Vanfleteren JR. 2001. Insulin-like signaling, metabolism, stress resistance and aging in Caenorhabditis elegans. Mech Ageing Dev 122:673-693.
25. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM. 1993. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089-1099.
26. Brindle PK, Montminy MR. 1992. The CREB family of transcription activators. Curr Opin Genet Dev 2:199-204.
27. Brion JP, Smith C, Couck AM, Gallo JM, Anderton BH. 1993. Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J Neurochem 61:2071-2080.
28. Brownlees J, Irving NG, Brion JP, Gibb BJ, Wagner U, Woodgett J, Miller CC. 1997. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes. Neuroreport 8:3251-3255.
29. Buee L, Delacourte A. 2001. Tau phosphorylation. In: Hof PR, Mobbs CV, editors. Functional neurobiology of aging. New York: Academic Press. p 315-332.
30. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR. 2000. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95-130.
31. Bullock BP, Habener JF. 1998. Phosphorylation of cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity, conformation, and increases net charge. Biochemistry 37:3795-3809.
32. Butner KA, Kirschner MW. 1991. Tau protein binds to microtubules through a flexible array of distributed weak sites. J Cell Biol 115:717-730.
33. Casanova MF, Carosella NW, Gold JM, Kleinman JE, Weinberger DR, Powers RE. 1993. A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia, Psychiatry Res 49:41-62.
34. Chen J, Kanai Y, Cowan NJ, Hirokawa N. 1992. Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons. Nature 360:674-677
35. Chu B, Soncin F, Price BD, Stevenson MA, Calderwood SK. 1996. Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1. J BioI Chem 271:30847-30857.
36. Cleveland DW, Hwo SY, Kirschner MW. 1977a. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol 116:227-247.
37. Cleveland DW, Hwo SY, Kirschner MW. 1977b. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 116:207-225.
38. Cohen P. 1999. The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction. Philos Trans B Soc Lond B Biol Sci 354:485-495.
39. Cohen P, Frame S. 2001. The renaissance of GSK3. Nat Rev, Mol Cell Biol 2:769-776.
40. Cross D, Vial C, Maccioni RB. 1993. A tau-like protein interacts with stress fibers and microtubules in human and rodent cultured cell lines. J Cell Sci 105:51-60.
41. Culbert AA, Brown MJ, Frame S, Hagen T, Cross DA, Bax B, Reith AD. 2001. GSK-3 inhibition by adenovira] FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity. FEBS Lett 507:288-294.
42. Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH. 2001. Crystal structure of glycogen synthase Kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105:721-732.
43. Davies P, Maloney AJ. 1976. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403-.
44. Davis GW, Schuster CM, Goodman CS. 1996. Genetic dissection of structural and functional components of synaptic plasticity. III. CREB is necessary for presynaptic functional plasticity. Neuron 17:669-679.
45. De Ferrari GV, Inestrosa NC. 2000. Wnt signaling function in Alzheimer's disease. Brain Res Brain Res Rev 33:1-12.
46. Deisseroth K, Bito H, Tsien RW. 1996. Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity. Neuron 16:89-101.
47. Diehl JA, Cheng M, Roussel MF, Sherr CJ. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499-3511.
48. D'Mello SR, Anelli R, Calissano P. 1994. Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons. Exp Cell Res 211:332-338.
49. Dominguez I, Green JB. 2001. Missing links in GSK3 regulation. Dev Biol 235:303-.313.
50. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E. 1998. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol 143:777-794.
51. Ekinci FJ, Shea TB. 2000. Phosphorylation of tau alters its association with the plasma membrane. Cell Mol Neurobiol 20:497-508.
52. Evans DB, Rank KB, Bhattacharya K, Thomsen DR, Gurney ME, Sharma SK. 2000. Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly. J Biol Chem 275:24977-24983.
53. Ferkey DM, Kimelman D. 2000. GSK-3: new thoughts on an old enzyme. Dev Biol 225:471-479.
54. Frame S, Cohen P, Biondi RM. 2001. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 7:1321-1327.
55. Gibb GM, Pearce J, Betts JC, Lovestone S, Hoffmann MM, Maerz W, Blackstock WP, Anderton BH. 2000. Differential effects of apolipoprotein E isoforms on phosphorylation at specific sites on tau by glycogen synthase kinase-3beta identified by nanoelectrospray mass spectrometry. FEBS Lett 485:99-103.
56. Ginty DD, Bonni A, Greenberg ME. 1994. Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell 77:713-725.
57. Godemann R, Biernat J, Mandelkow E, Mandelkow EM. 1999. Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain. FEBS Lett 454:157-164.
58. Goedert M. 1996. Tau protein and the neurofibrillary pathology, of Alzheimer's disease. Ann NY Acad Sci 777:121-131.
59. Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA. 1989. Cloning and sequencing of the eDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8:393-399.
60. Goedert M, Jakes R, Crowther RA, Six J, Lubke U, Vandermeeren M, Cras P, Trojanowski JQ, Lee VM. 1993. The abnormal phosphrylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 90:5066-5070.
61. Goedert M, Jakes R, Crowther RA, Cohen P, Vanmechelen E, Vandermeeren M, Cras P. 1994. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J 301:871-877.
62. Gong CX, Singh TJ, Grundke-Iqbal I, lqbal K. 1993. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61:921-927
63. Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K. 1995. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 65:732-738.
64. Gotz J, Chen F, van Dorpe J, Nitsch RM. 2001. Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta 42 fibrils. Science 293:1491-1495.
65. Grimes CA, Jope RS. 2001a. CREB DNA binding activity is inhibited by glycogen synthase kinase-3beta and facilitated by lithium. J Neurochem 78:1219-1232.
66. Grimes CA, Jope RS. 2001b. The multifaceted roles of glycogen synthase kinase 3 beta in cellular signaling. Prog Neurobiol 65:391-426.
67. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder Ll. 1986. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913-4917.
68. Gu Y, Oyama F. Ihara Y. 1996. Tau is widely expressed in rat tissues. J Neurochem 67:1235-1244.
69. Gustke N, Trinczek B, Biernat J, Mandelkow EM, Mandelkow E. 1994. Domains of tau protein and interactions with microtubules. Biochemistry 33:9511-9522.
70. Guzowski JF, McGaugh JL. 1997. Antisense oligodeoxynucleotide-mediated disruption of hippocampal cAMP response element binding protein levels impairs consolidation of memory for water maze training. Proc Natl Acad Sci USA 94:2693-2698.
71. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH. 1992. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 147:58-62.
72. Harr SD, Hollister RD, Hyman BT. 1996. Glycogen synthase kinase 3 alpha and 3 beta do not colocalize with neurofibrillary tangles. Neurobiol Aging 17:343-348.
73. Hartigan JA, Johnson GV. 1999. Transient increases in intracellular calcium result in prolonged site-selective increases in tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway J Biol Chem 274:21395-21401
74. Harwood AJ. 2001. Regulation of GSK-3: a cellular multiprocessor. Cell 105:821-824.
75. He B, Meng YH, Mivechi NF. 1998. Glycogen synthase kinase 3beta and extracellular signal-regulated kinase inactivate heat shock transcription factor 1 by facilitating the disappearance of transcriptionally active granules after heat shock. Mol Cell Biol 18:6624-6633.
76. Herz J. 2001. The LDL receptor gene family: (un)expected signal transducers in the brain. Neuron 29:571-581.
77. Himmler A, Drechsel D, Kirschner MW, Martin DW Jr. 1989. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains, Mol Cell Biol 9:1381-1388.
78. Hollander BA, Bennett GS. 1991. Lithium chloride alters cytoskeletal organization in growing, but not mature, cultured chick sensory neurons. J Neurosci Res 28:332-342.
79. Hong M, Lee VM. 1997. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272:19547-19553.
80. Hong M, Chen DC, Klein PS, Lee VM. 1997. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 272:25326 -25332.
81. Hoshi M, Sato M, Kondo S, Takashima A, Noguchi K, Takahashi M, Ishiguro K, Imahori K. 1995. Different localization of tau protein kinase I/glycogen synthase kinase-3 beta from glycogen synthase kinase-3 alpha in cerebellum mitochondria. J Biochem (Tokyo) 118:683-685.
82. Hoshi M. Takashima A, Noguchi K, Murayama, M, Sato M, Kondo S, Saitoh Y, Ishiguro K, Hoshino T, Imahori K. 1996. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain. Proc Natl Acad Sci USA 93:2719-2723.
83. Hoyer S. 2000. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update. Exp Gerontol 35:1363-1372.
84. Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR. 1993. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J 12:803-808.
85. Hwang SC, Jhon DY, Bae YS, Kim JH, Rhee SG. 1996. Activation of phospholipase C-gamma by the concerted action of tau proteins and arachidonic acid. J Biol Chem 271:18342-18349.
86. Illenberger S, Zheng-Fischhofer Q, Preuss U, Stamer K, Baumann K, Trinczek B, Biernat J, Godemann R, Mandelkow EM, Mamdelkow E. 1998. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol Biol Cell 9:1495-1512.
87. Imahori K, Uchida T. 1997. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J Biochem (Tokyo) 121:179-188.
88. Ingelson M, Vanmechelen E, Lannfelt L. 1996. Microtubule-associated protein tau in human fibroblasts with the Swedish Alzheimer mutation. Neurosci Lett 200:9-12.
89. Isagawa T, Mukai H, Oishi K, Taniguchi T, Hasegawa H, Kawamata T, Tanaka C, Ono Y. 2000. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta. Biochem Biophys Res Commun 273:209-212.
90. Ishiguro K, Ihara Y. Uchida T, Imahori K. 1988. A novel tubulin-dependent protein kinase forming a paired helical filament epitope on tau. J Biochem (Tokyo) 104:319-321.
91. Ishiguro K, Omori A, Takamatsu M, Sato K, Arioka M, Uchida T, Imahori K. 1992a. Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci Lett 148:202-206.
92. Ishiguro K, Takamatsu M, Tomizawa K, Omori A, Takahashi M, Arioka M, Uchida T, Imahori K. 1992b. Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J Biol Chem 267:10897-10901.
93. Ishiguro K, Shiratsuchi A, Sato S, Omori A, Arioka M, Kobayashi S, Uchida T, Imahori K. 1993. Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett 325:167-172.
94. Ishiguro K, Sato K, Takamatsu M, Park J, Uchida T, Imahori K. 1995, Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites. Neurosci Lett 202:81-84.
95. Itoh K, Tang TL, Neel BG, Sokol SY. 1995. Specific modulation of ectodermal cell fates in Xenopus embryos by glycogen synthase kinase. Development 121:3979-3988.
96. Jameson L, Frey T, Zeeberg B, Dalldorf F, Caplow M, 1980. Inhibition of microtubule assembly by phosphorylation of microtubule-associated proteins. Biochemistry. 19:2472-2479.
97. Ji L, Mochon E, Arcinas M, Boxer LM. 1996 . CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas. J Biol Chem 271:22687-22691.
98. Johnson GVW, Hartigan JA. 1998. Tau protein in normal and Alzheimer's disease brain: an update. Alzheimer's Dis Rev 3:125-141.
99. Johnson GVW, Jenkins SM. 1996. Tau protein in normal and Alzheimer's disease brain. Alzheimer's Dis Rev 1:38-54.
100. Kaang BK, Kandel ER, Grant SG. 1993. Activation of cAMP-responsive genes by stimuli that produce long-term facilitation in Aplysia sensory neurons. Neuron 10:427-435.
101. Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS. 2000. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28:449-459.
102. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS. 2001. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414:643-648.
103. Kang DE, Soriano S, Frosch MP, Collins T, Naruse S, Sisodia SS, Leibowitz G, Levine F, Koo EH. 1999. Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin signaling pathway. J Neurosci 19:4229-4237.
104. Kenessey A, Yen SH. 1993. The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments. Brain Res 629:40-46.
105. Kiang JG, Tsokos GC. 1998. Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther 80:183-201.
106. Kim L, Kimmel AR. 2000. GSK3, a master switch regulating cell-fate specification and tumorigenesis. Curr Opin Genet Dev 10:508-514.
107. Kim L, Liu J, Kimmel AR. 1999. The novel tyrosine kinase ZAK1 activates GSK3 to direct cell fate specification. Cell 99:399-408.
108. Kirschenbaum F, Hsu SC, Cordell B, McCarthy JV. 2001a. Glycogen synthase kinase-3beta regulates presenilin 1 c-terminal fragment levels. J Biol Chem 276:30701-30707.
109. Kirsehenbaum F, Hsu SC, Cordell B, McCarthy JV. 2001b. Substitution of a glycogen synthase kinase-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling. J Biol Chem 276:7366-7375.
110. Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J. 2002. Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J Neurosci 22:698-707.
111. Kline MP, Morimoto RI. 1997. Repression of the heat the heat shock factor 1 transcriptional activation domain is modulated by constitutive phosphorylation. Mol Cell Biol 17:2107-2115.
112. Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, Fischer P, Masters CL, Price DL. 1990. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 87:1561-1565.
113. Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I. 1993. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268:24374-24384
114. Kosik KS. 1997. Tau: structure and function. In: Avila J, Brandt R, Kosik KS, editors. Brain microtubule associated proteins. Amsterdam: Harwood Academic. p 43-52.
115. Kozlovsky N, Belmaker RH, Agam G. 2000. Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry 157:831-833.
116. Kozlovsky N, Belmaker RH, Agam G. 2001. Low GSK-3 activity in frontal cortex of schizophrenic patients. Schizopbr Res. 52:101-105.
117. Kozlovsky N, Belmaker RH, Agam C, 2002. GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur Neuropsychopharmacol 12:13-25.
118. Ksiezak-Reding H, Liu WK, Yen SH. 1992 . Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments. Brain Res 597:209-219.
119. Latimer DA, Gallo JM, Lovestone S, Miller CC, Reynolds CH, Marquardt B, Stabel S, Woodgett JR, Anderton BH. 1995 Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau. FEBS Lett 365:42-46.
120. Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G. 1998. Tau interacts with src-family non-receptor tyrosine kinases. J Cell Sci 111:3167-3177.
121. Leroy K, Brion JP. 1999. Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J Chem Neuroanat 16:279-293.
122. Leroy K, Menu R, Conreur JL, Dayanandan R, Lovestone S, Anderton BH, Brion JP. 2000. The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activity. FEBS Lett 465:34-38.
123. Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP. 2002. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Acta Neuropathol (Berl) 103:91-99.
124. Lesort M, Johnson GV. 2000. Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphororylation in primary cortical neurons. Neuroscience 99:305-316.
125. Lesort M, Jope RS, Johnson GV. 1999. Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem 72:576-584.
126. Levitan D, Lee J, Song L, Manning R, Wong G, Parker E, Zhang L. 2001. PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling. Proc Natl Acad Sci USA 98:12186-12190.
127. Lindwall G, Cole RD. 1984. Phosphorylation affects the ability of tau protein to promote microtubule assembly. J Biol Chem 259:5301-5305.
128. Loomis PA, Howard TH, Castleberry RP. Binder Ll. 1990. Identification of nuclear tau isoforms in human neuroblastoma cells. Proc Natl Acad Sci USA 87:8422-8426.
129. LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder Ll. 1995. Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc Natl Acad Sci USA 92:10369-10373.
130. Lovestone S, Reynolds CH. 1997. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78:309-324.
131. Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S, et al. 1994. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 4:1077-1086.
132. Lovestone S, Hartley CL, Pearce J, Anderton BH. 1996. Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules, Neuroscience 73:1145-1157.
133. Lovestone S, Davis DR, Webster MT, Kaech S, Brion JP, Matus A, Anderton BH. 1999. Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations. Biol Psychiatry 45:995-1003.
134. Lucas JJ, Hernandez F, Gomez-Ramon P, Moran MA, Hen R, Avila J. 2001. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20:27-39.
135. Maas T, Eidenmuller J, Brandt R. 2000. Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J Biol Chem 275:15733-15740.
136. Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, Vandenheede JR, Mandelkow E. 1992. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett 314:315-321.
137. Mandell JW, Banker GA. 1996a. Microtubule-associated proteins, phosphorylation gradients, and the establishment of neuronal polarity. Perspect Dev. Neurobiol 4:125-135.
138. Mandell JW, Banker GA. 1996b. A spatial gradient of tau protein phosphorylation in nascent axons. J Neurosci 16:5727-5740.
139. Matsuo ES, Shin RW, Billingsley ML, Van deVoorde A, O'Connor M, Trojanowski JQ, Lee VM. 1994. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13:989-1002.
140. Maynard Smith J. 1962. Review lectures on senescence. I. The causes of ageing. Proc R Soc Lond B Biol Sci 157:115-127.
141. Michel G, Mercken M, Murayama M, Noguchi K, Ishiguro K, Imahori K, Takashima A. 1998. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells. Biochim Biophys Acta 1380:177-182.
142. Migheli A, Butler M, Brown K, Shelanski ML. 1988. Light and electron microscope localization of the microtubule-associated tau protein in rat brain. J Neurosci 8:1846-1851.
143. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. 199.5. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238-1248.
144. Montminy MR, Bilezikjian LM. 1987. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328:175-178.
145. Moreno FJ, Medina M, Perez M, Montejo de Garcini E, Avila J. 1995. Glycogen synthase kinase 3 phosphorylates recombinant human tau protein at serine-262 in the presence of heparin (or tubulin). FEBS Lett 372:65-68.
146. Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST. 2002. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 21:281-293.
147. Morimoto RI. 1998. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 12:3788-3796.
148. Mudher A, Lovestone S. 2002. Alzheimer's disease - do tauists and baptists finally shake hands? Trends Neurosci 25:22-26.
149. Mudher A, Chapman S, Richardson J, Asuni A, Gibb G, Pollard C, Killick R, Iqbal T, Raymond L, Varndell I, Sheppard P, Makoff A, Gower E, Soden PE, Lewis P, Murphy M, Golde TE, Rupniak HT, Anderton BH, Lovestone S. 2001. Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase c/mitogen-activated protein kinase and c-Jun terminal kinase. J Neurosci 21:4987-4995.
150. Mulot SF, Hughes K, Woodgett JR, Anderton BH, Hanger DP. 1994. PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3 beta. FEBS Lett 349:359-364.
151. Munoz-Montano JR, Moreno FJ, Avila J, Diaz-Nido J. 1997. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett 411:183-188.
152. Murai H, Okazaki M, Kikuchi A. 1996. Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation. FEBS Lett 392:153-160.
153. Murayama M, Tanaka S, Palacino J, Murayama O, Honda T, Sun X, Yasutake K, Nihonmatsu N, Wolozin B, Takashima A. 1998. Direct association of presenilin-1 with beta-catenin. FEBS Lett 433:73-77.
154. Nomura S, Komiyama Y, Miyake T, Miyazaki Y, Kido H, Suzuki M, Kagawa H, Yanabu M, Takahashi H, Fukuhara S. 1994. Amyloid beta-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost 72:519-522.
155. Nonaka S, Hough CJ, Chuang DM. 1998. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 95:2642-2647.
156. Nuydens R, Van Den Kieboom G, Nolten C, Verhulst C, Van Osta P, Spittaels R, Van Den Haute C, De Feyter E, Geerts H, Van Leuven F. 2002. Coexpression of GSK-3beta corrects phenotypic aberrations of dorsal root ganglion cells, cultured from adult transgenic mice overexpressing human protein tau. Neurobiol Dis 9:38-48.
157. Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM. 1994. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39:669-673.
158. Paglini G, Peris L, Mascotti F, Quiroga S, Caceres A. 2000. Tau protein function in axonal formation. Neurochem Res 25:37-42
159. Papasozomenos SC, Binder LI. 1987. Phosphorylation determines two distinct species of Tau in the central nervous system. Cell Motil Cytoskel 8:210-226.
160. Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I 1997. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56:70-78.
161. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF. 1999. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58:1010-1019.
162. Perry, EK, Gibson PH, Blessed G, Perrry RH, Tomlinson BE. 1977. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci 34:247-265.
163. Planel E, Yasutake K, Fujita SC, Ishiguro K. 2001. Inhibition of protein phosphatase 2A overrides Tau protein kinase I /glycogen synthase kinase 3beta and Cyclin-dependant kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J Biol Chem 276:34298-34306.
164. Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ, Woodgett JR. 1992. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta 1114:147-162.
165. Poirier J. 1996. Apolipoprotein E in the brain and its role in Alzheimer's disease. J Psychiatry Neurosci 21:128-134.
166. Pugazhenthi S, Miller E, Sable C, Young P, Heidenreich KA, Boxer LM, Reusch JE. 1999. Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein. J Biol Chem 274:27529-27535.
167. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JE. 2000. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein, J Biol Chem 275:10761-10766.
168. Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian VH, Bierer LM, McCrystal J, Losonczy M, Davis KL. 1993. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study Biol Psychiatry, 33:255-260.
169. Ragano-Caracciolo M, Berlin WK, Miller MW, Hanover JA. 1998. Nuclear glycogen and glycogen synthase kinase 3. Biochem Biophys Res Commun 249:422-427,
170. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D. 1996. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein. N Engl J Med 334:752-758.
171. Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH. 2000. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem 74:1587-1595,
172. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD. 1999. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286:2358-2361.
173. Russ C, Lovestone S, Powell JF. 2001. Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease. Mol Psychiatry 6:320-324.
174. Sang H, Lu Z, Li Y, Ru B, Wang W, Chen J. 2001. Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules. Neurosci Lett 312:141-144.
175. Schoenfeld TA, Obar RA. 1994. Diverse distribution and function of fibrous microtubule-associated proteins in the nervous system. Int Rev Cytol 151:67-137.
176. Selkoe DJ. 2001 Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766.
177. Sengupta A, Wu Q, Grundke-Iqbal I, Iqbal K, Singh TJ. 1997. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. Mol Cell Biochem 167:99-105.
178. Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K. 1998. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch Biochem Biophys 357:299-309.
179. Shanavas A, Papasozomenos SC. 2000. Tau kinases in the rat heat shock model: possible implications for Alzheimer disease. Proc Natl Acad Sci USA 97:14139-14144.
180. Sheng M, Thompson MA, Greenberg ME. 1991. CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252:1427-1430.
181. Shiurba RA, Ishiguro K, Takahashi M, Sato K, Spooner ET, Mercken M, Yoshida R, Wheeloek TR, Yanagawa H, Imahori K, Nixon RA. 1996. Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology. Brain Res 737:119-132.
182. Silva AJ, Kogan JH, Frankland PW, Kida S. 1998. CREB and memory, Annu Rev Neurosci 21:127-148.
183. Singh TJ, Zaidi T, Grundke-Iqbal I, Iqbal K. 1995. Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases. FEBS Lett 358:4-8.
184. Solano DC, Sironi M, Bonfini C, Solerte SB, Govoni S, Racchi M. 2000. Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J 14:1015-1022.
185. Song JS, Yang SD. 1995. Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain. J Protein Chem 14:95-105.
186. Soriano S, Kang DE, Fu M, Pestell R, Chevallier N, Zheng H, Koo EH. 2001. Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J Cell Biol 152:785-794.
187. Sperber BR, Leight S, Goedert M, Lee VM. 1995. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neurosci Lett 197:149-153.
188. Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I, Geerts H, Mercken M, Sciot R, Van Lommel A, Loos R, Van Leuven F. 1999. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 155:2153-2165.
189. Spittaels K, Van Den Haute C, Van Dorpe J, Geerts H, Mercken M, Bruynseels K, Lasrado R, Vandezande K, Laenen I, Boon T. Van Lint J, Vandenheede J, Moechars D, Loos R, Van Leuven F. 2000. Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem 275:41340-41349.
190. Struthers RS, Vale WW, Arias C, Sawchenko PE, Montminy MR. 1991. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature 350:622-624.
191. Sun X, Tashiro T, Hirai S, Yamamoto H, Miyamoto E, Komiya Y. 1995. Preparation of tau from the peripheral nerve: presence of insoluble low molecular weight tau with high phosphorylation. Biochem Biophys Res Commun 210:338-344.
192. Sun W, Qureshi HY, Cafferty PW, Sobue K, Agarwal-Mawal A, Neufield KD, Paudel HK. 2002a. Glycogen synthase kinase-3beta is complexed with Tau protein in brain microtubules. J Biol Chem 277:11933-11940.
193. Sun X, Cole GM, Chu T, Xia W, Galasko D, Yamaguchi H, Tanemura K, Frautschy SA, Takashima A. 2002b. Intracellular amyloid beta is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines. NeurobioI Aging 23:195-203.
194. Sun X, Sato S, Murayama O, Murayama M, Park J-M, Yamaguchi H, Takashima A. 2002c. Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100. Neurosci Lett 321:61-64.
195. Sutherland C, Cohen P. 1994. The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro. FEBS Lett 338:37-42.
196. Sutherland C, Leighton IA, Cohen P. 1993. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296:15-19.
197. Szendrei GI, Lee VM, Otvos L Jr. 1993. Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location. J Neurosci Res 34:243-249.
198. Takahashi M, Tomizawa K, Kato R, Sato K, Uchida T, Fujita SC, Imahori K. 1994. Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. J Neurochem 63:245-255.
199. Takahashi M, Yasutake K, Tomizawa K. 1999. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons. J Neurochem 73:2073-2083.
200. Takashima A, Noguchi K, Sato K, Hoshino T, Imahori K. 1993. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci USA 90:7789-7793.
201. Takashima A, Yamaguchi H, Noguchi K, Michel G, Ishiguro K, Sato K, Hoshino T, Hoshi M, Imahori K. 1995. Amyloid beta peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3 beta in rat hippocampal neurons. Neurosci Lett 198:83-86.
202. Takashima A, Noguchi K, Michel G, Mercken M, Hoshi M, Ishiguro K, Imahori K. 1996. Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neurosci Lett 203:33-36.
203. Takashima A, Murayama M, Murayama O, Kohno T, Honda T, Yasutake K, Nihonmatsu N, Mercken M, Yamaguchi H, Sugihara S, Wolozin B. 1998. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc Natl Acad Sci USA 95:9637-9641.
204. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X. 2000. LDL-receptor-related proteins in Wnt signal transduction. Nature 407:530-535.
205. Tatebayashi Y, lqbal K, Grundke-Iqbal I. 1999. Dynamic regulation of expression and phosphorylation of tau by fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus. J Neurosci 19:5245-5254.
206. Thomas GM, Frame S, Goedert M, Nathke I, Polakis P, Cohen P. 1999. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin. FEBS Lett 458:247-251.
207. Trojanowski JQ, Lee VM. 1994, Paired helical filament tau in Alzheimer's disease. The kinase connection. Am J Pathol 144:449-453.
208. Tucker RP, 1990. The roles of microtubule-associated proteins in brain morphogenesis: a review. Brain Res Rev 15:101-120.
209. Utton MA, Vandecandelaere A, Wagner U, Reynolds CH, Gibb GM, Miller CC, Bayley PM, Anderton BH, 1997. Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly. Biochem J 323(Pt 3):741-747.
210. Vanier MT, Neuville P, Michalik L, Launay JF. 1998. Expression of specific tau exons in normal and tumoral pancreatic acinar cells. J Cell Sci 111:1419-1432.
211. Volonté C, Rukenstein A. 1993. Lithium chloride promotes short-term survival of PC12 cells after serum and NGF deprivation. Lithium 4:211-219.
212. Waeber G, Habener JF, 1991. Nuclear translocation and DNA recognition signals colocalized within the bZIP domain of cyclic adenosine 3′,5′-monophosphate response element-binding protein CREB. Mol Endocrinol 5:1431-1438.
213. Wagner U, Utton M, Gallo JM, Miller CC. 1996. Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J Cell Sci 109(Pt 6):1537-1543.
214. Wang QM, Fiol CJ, DePaoli-Roach AA, Roach PJ. 1994a. Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J Biol Chem 269:14566-14574.
215. Wang QM, Roach PJ, Fiol CJ. 1994b. Use of a synthetic peptide as a selective substrate for glycogen synthase kinase 3. Anal Biochem 220:397-402.
216. Wang JZ, Wu Q, Smith A, Grundke-Iqbal I, Iqbal K. 1998. Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett 436:28-34.
217. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. 1975. A protein factor essential for microtubule assembly Proc Natl Acad Sci USA 72:1858-1862.
218. Welsh GI, Wilson C, Proud CG. 1996. GSK3: a SHAGGY frog story. Trends Cell Biol 6:274-279.
219. White P, Hiley CR, Goodhardt MJ, Carraseo LH, Keet JP, Williams IE, Bowen DM. 1977. Neocortical cholinergic neurons in elderly people. Lancet 1:668-671.
220. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. 1982. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-1239.
221. Wilson BE, Mochon E, Boxer LM. 1996. Induction of bcl-2 expression by phosphorylated CBEB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol 16:5546-5556.
222. Woodgett JR. 1990. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9:2431-2438.
223. Woodgett JR. 1994. Regulation and functions of the glycogen synthase kinase-3 subfamily. Semin Cancer Biol 5:269-275.
224. Xie H, Litersky JM, Hartigan JA, Jope RS, Johnson GV. 1998. The interrelationship between selective tau phosphorylation and microtubule association. Brain Res 798:173-183.
225. Xing J, Ginty DD, Greenberg ME. 1996. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273:959-963.
226. Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA, Imahori K. 1996. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol (Berl) 92:232-241.
227. A) as a microtubule protein kinase in the brain. J Protein Chem 10:171-181.
228. Yang SD, Song JS, Yu JS, Shiah SG. 1993a. Protein kinase FA/GSK-3 phosphorylates tau on Ser235-Pro and Ser404-Pro that are abnormally phosphorylated in Alzheimer's disease brain. J Neurochem 61:1742-1747.
229. Yang SD, Yu JS, Liu WK, Yen SH. 1993b. Synergistic control mechanism for abnormal site phosphorylation of Alzheimer's diseased brain tau bv kinase FA/GSK-3 alpha. Biochem Biophys Res Commun 197:400-406
230. Yang SD, Yu JS, Shiah SG, Huang JJ. 1994. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain. J Neurochem 63:1416-1425.
231. Yang SD, Yu JS, Lee TT, Yang CC, Ni MH, Yang YY. 1995. Dysfunction of protein kinase FA/GSK-3 alpha in lymphocytes of patients with schizophrenic disorder, J Cell Biochem 59:108-116.
232. Yoshida H, Ihara Y. 1993. Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau. J Neurochem 61:1183-1186.
233. Zheng-Fischhofer Q, Biernat J, Mandelkow EM, Illenberger S, Godemann R, Mandelkow E. 1998. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser2l4 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem 252:549-552.